What is Rare Disease?
World Health Organization (WHO) defines a rare disease as a medical condition that affects fewer than 1 in 2,000 people in any of its defined global regions. This framework is gaining international recognition, with over 7,000 identified rare diseases collectively impacting more than 300 million people worldwide. While the prevalence threshold is the standard, most rare diseases lack approved treatments, often present with complex symptoms, and a significant portion are genetic and manifest in childhood.
Common Challenges Facing Rare Disease Communities
-
Diagnostic Delays - Average 5-7 years to reach correct diagnosis, often involving misdiagnosis and doctor shopping
-
Limited Treatment Options - Only 5% of rare diseases have FDA-approved treatments available
-
High Medical Costs - Expensive treatments with limited insurance coverage, creating significant financial burden
-
Social Isolation - Lack of disease awareness leads to social difficulties and psychological stress for patients
Genetic/Metabolic Disorders
Huntington's Disease
A hereditary neurodegenerative disorder caused by a mutation in the HTT gene, leading to progressive breakdown of nerve cells in the brain. Symptoms typically appear in mid-adulthood and include involuntary movements, emotional problems, and cognitive decline.
Cystic Fibrosis
An inherited disorder affecting the lungs and digestive system, caused by mutations in the CFTR gene that result in thick, sticky mucus production. This mucus clogs airways and traps bacteria, leading to serious lung infections and digestive problems.
Gaucher Disease
A genetic disorder caused by deficiency of the enzyme glucocerebrosidase, leading to harmful accumulation of fatty substances in organs and tissues. The three types range from mild to severe, affecting the liver, spleen, bones, and sometimes the nervous system.
Phenylketonuria (PKU)
An inherited metabolic disorder where the body cannot break down the amino acid phenylalanine due to a defective enzyme. Without strict dietary management from birth, toxic levels of phenylalanine build up, causing intellectual disability and other serious health problems.
Tay-Sachs Disease
A fatal genetic disorder that progressively destroys nerve cells in the brain and spinal cord due to absence of the enzyme hexosaminidase A. Most commonly affecting infants, it leads to severe neurological deterioration and death by early childhood.
Fabry Disease
An X-linked genetic disorder caused by deficiency of the enzyme alpha-galactosidase A, leading to accumulation of globotriaosylceramide in cells. This buildup damages the kidneys, heart, nervous system, and skin, with symptoms often appearing in childhood or adolescence.
Neurological Disorders
ALS (Lou Gehrig's Disease)
A progressive neurodegenerative disease that attacks motor neurons controlling voluntary muscle movement, leading to muscle weakness and eventual paralysis. Most patients survive 2-5 years after diagnosis, though some live much longer with supportive care.
Rett Syndrome
A rare genetic neurological disorder that almost exclusively affects girls, caused by mutations in the MECP2 gene. After normal early development, children experience regression in language and motor skills, leading to severe intellectual and physical disabilities.
Tourette Syndrome
A neurological disorder characterized by repetitive, involuntary movements and vocalizations called tics, typically beginning in childhood. While often portrayed dramatically in media, most cases are mild and many people learn to manage their symptoms effectively.
Spinal Muscular Atrophy
A genetic neuromuscular disorder caused by loss of motor neurons in the spinal cord, resulting in progressive muscle weakness and atrophy. The severity ranges from fatal infantile forms to milder adult-onset types, depending on the amount of functional SMN protein produced.
Friedreich's Ataxia
A progressive genetic disorder affecting the nervous system, causing deterioration of nerve tissue in the spinal cord and peripheral nerves. Symptoms include loss of coordination, muscle weakness, speech problems, and often heart complications.
Myasthenia Gravis
A chronic autoimmune neuromuscular disorder where antibodies block communication between nerves and muscles, causing weakness that worsens with activity. Common symptoms include drooping eyelids, double vision, difficulty speaking, and muscle fatigue that improves with rest.